MD Anderson has earned its sixth Magnet designation and first Magnet with Distinction rating from the American Nurses Credentialing Center (ANCC) Magnet Recognition Program, the highest international ...

The Cancer Prevention and Research Institute of Texas awarded the university more than $2.4 million to tailor treatments for certain cancers.

Matt Kampmeier of Plymouth was diagnosed with Stage 4 glioblastoma and lost some of his vision -- but still plays pickleball ...

The Houston Chronicle analyzed the most recent salary data from Texas' lone independent university and its seven university ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

A study identifies three patient subgroups in large B-cell lymphoma, revealing distinct responses to CD19 CAR T cell therapy ...

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three ...

Preoperative stereotactic radiation therapy (SRT) was feasible -- and may even be more favorable -- compared with ...

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

The clinical lab giant is working with MD Anderson on an LDT for assessing cancer risk to drive uptake of recommended screenings and identify high-risk individuals for evaluation.